Brind.

Oramed Pharmaceuticals partnered with Hefei Tianhui Biotech to operate an oral insulin facility in Hefei.

1 report, 1 independent Updated Jul 29
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Oramed Pharmaceuticals partnered with Hefei Tianhui Biotech to operate an oral insulin facility in Hefei.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • Zacks Small Cap ResearchWith Substantial Liquidity, ORMP Has Generated Gains & Income From Investment Portfolio By M. Marin NASDAQ:ORMP READ THE FULL ORMP RESEARCH REPORT Company maintains substantial liquidity Oramed Pharm